-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Cerus (NASDAQ:CERS) Reaches New 52-Week Low at $3.42
Cerus (NASDAQ:CERS) Reaches New 52-Week Low at $3.42
Cerus Co. (NASDAQ:CERS – Get Rating) shares hit a new 52-week low during trading on Tuesday . The company traded as low as $3.42 and last traded at $3.42, with a volume of 30076 shares. The stock had previously closed at $3.47.
Cerus Trading Down 1.7 %
The stock has a market cap of $603.88 million, a P/E ratio of -14.46 and a beta of 1.14. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.08 and a quick ratio of 1.73. The business's 50 day simple moving average is $4.68 and its 200 day simple moving average is $4.98.
Get Cerus alerts:Insider Activity
In other news, insider Richard J. Benjamin sold 10,000 shares of Cerus stock in a transaction that occurred on Tuesday, August 9th. The shares were sold at an average price of $5.12, for a total value of $51,200.00. Following the completion of the transaction, the insider now owns 172,665 shares in the company, valued at $884,044.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 7.33% of the stock is currently owned by corporate insiders.
Institutional Inflows and Outflows
A number of institutional investors have recently modified their holdings of the company. Legal & General Group Plc raised its stake in shares of Cerus by 9.9% in the second quarter. Legal & General Group Plc now owns 328,358 shares of the biotechnology company's stock valued at $1,737,000 after acquiring an additional 29,597 shares during the last quarter. ExodusPoint Capital Management LP raised its position in Cerus by 3.8% in the 2nd quarter. ExodusPoint Capital Management LP now owns 233,339 shares of the biotechnology company's stock worth $1,234,000 after purchasing an additional 8,516 shares during the last quarter. Walleye Capital LLC bought a new position in Cerus in the 2nd quarter worth approximately $154,000. Goldman Sachs Group Inc. raised its position in Cerus by 102.4% in the 2nd quarter. Goldman Sachs Group Inc. now owns 863,845 shares of the biotechnology company's stock worth $4,570,000 after purchasing an additional 437,101 shares during the last quarter. Finally, Tamarack Advisers LP raised its position in Cerus by 21.2% in the 2nd quarter. Tamarack Advisers LP now owns 2,000,000 shares of the biotechnology company's stock worth $10,580,000 after purchasing an additional 350,000 shares during the last quarter. Institutional investors own 84.72% of the company's stock.About Cerus
(Get Rating)
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion.
Further Reading
- Get a free copy of the StockNews.com research report on Cerus (CERS)
- Build A Better Tech Portfolio With Jabil Inc.
- Is There Value In These Growth Stocks?
- Autodesk Is A Mature Company Still Acting Like A Growth Stock
- MarketBeat Podcast, 3 Stocks to Watch Newmont Mining, Walmart, AMC
- Is the Market Overreacting with Shopify Stock?
Receive News & Ratings for Cerus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerus and related companies with MarketBeat.com's FREE daily email newsletter.
Cerus Co. (NASDAQ:CERS – Get Rating) shares hit a new 52-week low during trading on Tuesday . The company traded as low as $3.42 and last traded at $3.42, with a volume of 30076 shares. The stock had previously closed at $3.47.
賽樂斯公司(納斯達克代碼:CERS-GET Rating)的股價週二創下52周新低。該公司股價最低跌至3.42美元,最新報3.42美元,成交量為30076股。該股此前收盤價為3.47美元。
Cerus Trading Down 1.7 %
Cerus交易下跌1.7%
The stock has a market cap of $603.88 million, a P/E ratio of -14.46 and a beta of 1.14. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.08 and a quick ratio of 1.73. The business's 50 day simple moving average is $4.68 and its 200 day simple moving average is $4.98.
該股市值為6.0388億美元,市盈率為-14.46,貝塔係數為1.14。該公司的債務權益比為0.53,流動比率為2.08,速動比率為1.73。該業務的50日簡單移動均線切入位為4.68美元,200日簡單移動均線切入位為4.98美元。
Insider Activity
內幕活動
In other news, insider Richard J. Benjamin sold 10,000 shares of Cerus stock in a transaction that occurred on Tuesday, August 9th. The shares were sold at an average price of $5.12, for a total value of $51,200.00. Following the completion of the transaction, the insider now owns 172,665 shares in the company, valued at $884,044.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 7.33% of the stock is currently owned by corporate insiders.
在其他新聞方面,內部人士理查德·J·本傑明在8月9日星期二的一筆交易中出售了10,000股Cerus股票。這些股票的平均價格為5.12美元,總價值為51,200.00美元。交易完成後,這位內部人士現在擁有該公司172,665股股票,價值884,044.80美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的,該文件可通過此超鏈接。7.33%的股份目前由企業內部人士持有。
Institutional Inflows and Outflows
機構資金流入和流出
About Cerus
關於Cerus
(Get Rating)
(獲取評級)
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion.
Cerus公司是一家生物醫藥產品公司。該公司專注於開發攔截血液系統並將其商業化,以增強血液安全。其攔截血液系統,這是一項控制生物複製的專利技術,旨在減少用於輸血的捐獻血液成分中的血源性病原體。
Further Reading
進一步閲讀
- Get a free copy of the StockNews.com research report on Cerus (CERS)
- Build A Better Tech Portfolio With Jabil Inc.
- Is There Value In These Growth Stocks?
- Autodesk Is A Mature Company Still Acting Like A Growth Stock
- MarketBeat Podcast, 3 Stocks to Watch Newmont Mining, Walmart, AMC
- Is the Market Overreacting with Shopify Stock?
- 免費獲取StockNews.com關於Cerus的研究報告(CERS)
- 與捷普公司一起打造更好的技術產品組合。
- 這些成長型股票有價值嗎?
- 歐特克是一家成熟的公司,仍是一隻成長型股票
- MarketBeat Podcast,3只股票關注紐蒙特礦業、沃爾瑪、AMC
- 市場是否對Shopify Stock反應過度?
Receive News & Ratings for Cerus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerus and related companies with MarketBeat.com's FREE daily email newsletter.
接受《Cerus Daily》的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Cerus和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧